SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-044023
Filing Date
2024-04-12
Accepted
2024-04-12 16:05:09
Documents
21
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A lbph_2024_definitive_pro.htm DEF 14A 717488
2 GRAPHIC img156075999_0.jpg GRAPHIC 111121
3 GRAPHIC img156075999_1.jpg GRAPHIC 40943
4 GRAPHIC img156075999_2.jpg GRAPHIC 18497
5 GRAPHIC img156075999_3.jpg GRAPHIC 45187
6 GRAPHIC img156075999_4.jpg GRAPHIC 43606
7 GRAPHIC img156075999_5.jpg GRAPHIC 44689
8 GRAPHIC img156075999_6.jpg GRAPHIC 48997
9 GRAPHIC img156075999_7.jpg GRAPHIC 44303
10 GRAPHIC img156075999_8.jpg GRAPHIC 42688
11 GRAPHIC img156075999_9.jpg GRAPHIC 42350
12 GRAPHIC img156075999_10.jpg GRAPHIC 227774
13 GRAPHIC img156075999_11.jpg GRAPHIC 25180
14 GRAPHIC img156075999_12.jpg GRAPHIC 17373
15 GRAPHIC img156075999_13.jpg GRAPHIC 78485
16 GRAPHIC img156075999_14.jpg GRAPHIC 67951
17 GRAPHIC img156075999_15.jpg GRAPHIC 46758
18 GRAPHIC img156075999_16.jpg GRAPHIC 46101
19 GRAPHIC img156075999_17.jpg GRAPHIC 18497
20 GRAPHIC img156075999_18.jpg GRAPHIC 290506
21 GRAPHIC img156075999_19.jpg GRAPHIC 144423
  Complete submission text file 0000950170-24-044023.txt   2712230
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40192 | Film No.: 24841431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)